Method for improving catalytic activity of chloroperoxidase through chemical modification of small molecule fatty acid
A chloroperoxidase and catalytic activity technology, applied in the field of enzyme engineering, can solve problems such as difficulty, complex structure, and many influencing factors, and achieve the effect of improving high temperature thermal stability and improving catalytic activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] 1. Prepare the solution
[0022] Dissolve 0.142g octadecanoic acid in phosphate buffer solution with a mass fraction of 4% dimethyl sulfoxide to prepare 100mL of octadecanoic acid solution with a concentration of 0.5mmol / L; -4 The mol / L chloroperoxidase solution was diluted to 100 mL with phosphate buffer solution with a pH value of 5.0, and the concentration was prepared to be 5×10 -6 mol / L chloroperoxidase solution.
[0023] 2. Pretreatment dialysis bag
[0024] Boil the dialysis bag with 150 mL of 50% ethanol water solution by volume fraction for 1 hour, cool it down, and wash it with 50% ethanol water solution and 0.01mol / L NaHCO successively. 3 aqueous solution, 0.001mol / L ethylenediaminetetraacetic acid aqueous solution, washed with distilled water, then soaked in distilled water, and placed in a refrigerator at 4°C until use.
[0025] 3. Modification reaction
[0026] 3mL 5×10 -6 mol / L chloroperoxidase solution and 0.6mL 0.5mmol / L octadecanoic acid solution ...
Embodiment 2
[0030] In the preparation solution step 1 of embodiment 1, 0.1g dodecanoic acid is dissolved in the phosphate buffer solution of the dimethyl sulfoxide of 4% by mass fraction, preparation concentration is the dodecanoic acid solution 100mL of 0.5mmol / L, Other steps of this step are the same as in Example 1. In modification reaction step 3, 3 mL of 5×10 -6 mol / L chloroperoxidase solution and 0.6mL 0.5mmol / L dodecanoic acid solution were mixed evenly in a 5mL cryovial, placed in an ice bath and stirred for 60 minutes. The other steps were the same as in Example 1 to prepare dodecanoic acid-modified chloroperoxidase.
Embodiment 3
[0032] In the preparation solution step 1 of embodiment 1, 0.114g myristic acid is dissolved in the phosphate buffer solution of the dimethyl sulfoxide of 4% by mass fraction, and preparation concentration is 100mL of the myristic acid solution of 0.5mmol / L, Other steps of this step are the same as in Example 1. In modification reaction step 3, 3 mL of 5×10 -6 The mol / L chloroperoxidase solution and 0.6mL 0.5mmol / L myristic acid solution were mixed evenly in a 5mL cryovial, placed in an ice bath and stirred for 60 minutes. The other steps were the same as in Example 1 to prepare myristic acid-modified chloroperoxidase.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 